TrademarkOpen
Search / United States / 90056265

Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.

🇺🇸 United States · Trademark

EULEXIN

Registered
Used for: ANTI-ANDROGEN ANTI-CANCER PREPARATION

Class 5 – Pharmaceuticals & supplements

Status timeline

  1. 20 Jul 2020
    Application filed
    New Application Entered
  2. 29 Oct 2020
    Assigned to an examining attorney
    Assigned To Examiner
  3. 5 Nov 2020
    Approved for publication
    Approved For Pub - Principal Register
  4. 8 Dec 2020
    Published for opposition
    Published For Opposition
  5. 2 Feb 2021
    Notice of allowance issued — statement of use required
    Noa Mailed - Sou Required From Applicant
  6. 3 Jun 2021
    Statement-of-use extension 1 granted
    Sou Extension 1 Granted
  7. 21 Jan 2022
    Statement of use filed
    Teas Statement Of Use Received
  8. 25 Feb 2022
    Statement of use accepted
    Allowed Principal Register - Sou Accepted
  9. 26 Feb 2022
    Statement of use accepted
    Notice Of Acceptance Of Statement Of Use E-Mailed
  10. 5 Apr 2022
    Registered on the Principal Register
    Registered-Principal Register
  11. 23 Jun 2022
    Ownership assignment recorded
    Automatic Update Of Assignment Of Ownership
  12. 29 Jun 2022
    Ownership assignment recorded
    Automatic Update Of Assignment Of Ownership
  13. 30 Oct 2024
    Ownership assignment recorded
    Automatic Update Of Assignment Of Ownership
All 30 events
2024-10-30Automatic Update Of Assignment Of Ownership
2024-09-12Teas Change Of Owner Address Received
2024-09-12Applicant/Correspondence Changes (Non-Responsive) Entered
2024-09-12Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
2024-09-12Attorney/Dom.rep.revoked And/Or Appointed
2024-09-12Teas Change Of Correspondence Received
2022-06-29Automatic Update Of Assignment Of Ownership
2022-06-23Automatic Update Of Assignment Of Ownership
2022-04-05Registered-Principal Register
2022-02-26Notice Of Acceptance Of Statement Of Use E-Mailed
2022-02-25Allowed Principal Register - Sou Accepted
2022-02-17Teas Change Of Owner Address Received
2022-02-17Teas Change Of Correspondence Received
2022-02-17Applicant/Correspondence Changes (Non-Responsive) Entered
2022-02-10Statement Of Use Processing Complete
2022-02-09Case Assigned To Intent To Use Paralegal
2022-01-21Teas Statement Of Use Received
2022-01-21Use Amendment Filed
2021-06-05Notice Of Approval Of Extension Request E-Mailed
2021-06-03Sou Teas Extension Received
2021-06-03Sou Extension 1 Filed
2021-06-03Sou Extension 1 Granted
2021-02-02Noa Mailed - Sou Required From Applicant
2020-12-08Published For Opposition
2020-12-08Official Gazette Publication Confirmation E-Mailed
2020-11-18Notification Of Notice Of Publication E-Mailed
2020-11-05Approved For Pub - Principal Register
2020-10-29Assigned To Examiner
2020-08-12New Application Office Supplied Data Entered
2020-07-20New Application Entered

Goods & services by class

Class 5 Pharmaceuticals & supplements

ANTI-ANDROGEN ANTI-CANCER PREPARATION

First use anywhere 20 Jan 2022 · First use in commerce 20 Jan 2022

Owner details

See the official record for contact details. View official record →

Source & freshness

Source: the official United States trademark register. This record was last updated on 17 Sep 2024; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.